• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The occurrence of interval cancers in the Nijmegen screening programme.奈梅亨筛查项目中间隔期癌症的发生情况。
Br J Cancer. 1989 Jun;59(6):929-32. doi: 10.1038/bjc.1989.196.
2
The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.乳腺钼靶筛查项目中目前乳腺癌的可检测性。对间期癌和筛查发现癌的既往钼靶片回顾。
Cancer. 1993 Sep 15;72(6):1933-8. doi: 10.1002/1097-0142(19930915)72:6<1933::aid-cncr2820720623>3.0.co;2-n.
3
Survival in interval breast cancer in the DOM screening programme.DOM筛查项目中区间性乳腺癌的生存率。
Eur J Cancer. 1995 Oct;31A(11):1830-5. doi: 10.1016/0959-8049(95)00324-c.
4
Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.从屏-片乳腺摄影向全视野数字化乳腺筛查摄影转变之前、期间及之后的间期乳腺癌特征
BMC Cancer. 2017 May 5;17(1):315. doi: 10.1186/s12885-017-3294-5.
5
The detectability of breast cancer by screening mammography.通过乳腺钼靶筛查对乳腺癌的可检测性。
Br J Cancer. 1995 Feb;71(2):337-9. doi: 10.1038/bjc.1995.67.
6
Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.荷兰奈梅亨的长期乳腺癌筛查:1975年至1992年的九轮筛查
J Epidemiol Community Health. 1996 Jun;50(3):353-8. doi: 10.1136/jech.50.3.353.
7
Missed and true interval and screen-detected breast cancers in a population based screening program.基于人群的筛查项目中漏诊和真阳性的乳腺癌。
Acad Radiol. 2011 Apr;18(4):454-60. doi: 10.1016/j.acra.2010.11.014. Epub 2011 Jan 8.
8
Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.乳腺钼靶密度对乳腺癌筛查性能的影响:荷兰奈梅亨的一项研究。
J Epidemiol Community Health. 1998 Apr;52(4):267-71. doi: 10.1136/jech.52.4.267.
9
So-called interval cancers of the breast. Pathologic and radiologic analysis of sixty-four cases.所谓的乳腺间期癌。64例病例的病理与放射学分析。
Cancer. 1982 Jun 15;49(12):2527-33. doi: 10.1002/1097-0142(19820615)49:12<2527::aid-cncr2820491220>3.0.co;2-e.
10
A review of interval breast cancers diagnosed among participants of the Nova Scotia Breast Screening Program.回顾新斯科舍省乳房筛查计划参与者中诊断出的间隔期乳腺癌。
Radiology. 2013 Jan;266(1):96-103. doi: 10.1148/radiol.12102348. Epub 2012 Nov 20.

引用本文的文献

1
Which type of cancer is detected in breast screening programs? Review of the literature with focus on the most frequent histological features.在乳腺癌筛查计划中检测到哪种类型的癌症?文献综述,重点关注最常见的组织学特征。
Pathologica. 2021 Apr;113(2):85-94. doi: 10.32074/1591-951X-123.
2
Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.立陶宛乳腺癌筛查计划:7 年乳腺 X 线筛查后的间期癌和计划灵敏度。
Cancer Control. 2019 Jan-Dec;26(1):1073274819874122. doi: 10.1177/1073274819874122.
3
Interobserver agreement in breast radiological density attribution according to BI-RADS quantitative classification.BI-RADS 定量分类法评估乳腺放射密度时的观察者间一致性。
Radiol Med. 2012 Jun;117(4):519-28. doi: 10.1007/s11547-011-0777-3. Epub 2012 Jan 7.
4
Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients.乳腺钼靶筛查作为绝经后乳腺癌患者生存预测指标的作用。
Br J Cancer. 2006 Jan 16;94(1):147-51. doi: 10.1038/sj.bjc.6602895.
5
Breast density as a determinant of interval cancer at mammographic screening.乳腺密度作为乳腺钼靶筛查时区间性癌症的一个决定因素。
Br J Cancer. 2004 Jan 26;90(2):393-6. doi: 10.1038/sj.bjc.6601548.
6
High expression of the trefoil protein TFF1 in interval breast cancers.三叶因子蛋白TFF1在间期乳腺癌中的高表达。
Am J Pathol. 2001 Jul;159(1):215-21. doi: 10.1016/S0002-9440(10)61687-2.
7
A study of interval breast cancer within the NHS breast screening programme.英国国家医疗服务体系(NHS)乳腺筛查项目中的间期乳腺癌研究。
J Clin Pathol. 2000 Feb;53(2):140-6. doi: 10.1136/jcp.53.2.140.
8
Interval cancers in the Dutch breast cancer screening programme.荷兰乳腺癌筛查项目中的间期癌
Br J Cancer. 1999 Nov;81(5):912-7. doi: 10.1038/sj.bjc.6690786.
9
Sensitivity, specificity and predictive values of breast imaging in the detection of cancer.乳腺成像在癌症检测中的敏感性、特异性及预测值。
Br J Cancer. 1997;76(3):377-81. doi: 10.1038/bjc.1997.393.
10
A comparative audit of prevalent, incident and interval cancers in the Avon breast screening programme.对雅芳乳腺筛查项目中现患癌、新发癌和间期癌的比较性审计。
Ann R Coll Surg Engl. 1997 Jul;79(4):272-5.

本文引用的文献

1
So-called interval cancers of the breast. Pathologic and radiologic analysis of sixty-four cases.所谓的乳腺间期癌。64例病例的病理与放射学分析。
Cancer. 1982 Jun 15;49(12):2527-33. doi: 10.1002/1097-0142(19820615)49:12<2527::aid-cncr2820491220>3.0.co;2-e.
2
Evidence of breast cancer mortality reduction: aggressive screening in women under age 50.
AJR Am J Roentgenol. 1982 May;138(5):911-6. doi: 10.2214/ajr.138.5.911.
3
Ten- to fourteen-year effect of screening on breast cancer mortality.筛查对乳腺癌死亡率的10至14年影响。
J Natl Cancer Inst. 1982 Aug;69(2):349-55.
4
Breast Cancer Detection Demonstration Project: five-year summary report.乳腺癌检测示范项目:五年总结报告
CA Cancer J Clin. 1982 Jul-Aug;32(4):194-225. doi: 10.3322/canjclin.32.4.194.
5
The DOM project for the early detection of breast cancer, Utrecht, The Netherlands.荷兰乌得勒支的乳腺癌早期检测DOM项目。
J Chronic Dis. 1984;37(1):1-44. doi: 10.1016/0021-9681(84)90123-1.
6
Mammographically occult breast cancer. A pathologic and radiologic study.乳腺钼靶隐匿性乳腺癌。一项病理学与放射学研究。
Cancer. 1983 Nov 15;52(10):1810-9. doi: 10.1002/1097-0142(19831115)52:10<1810::aid-cncr2820521009>3.0.co;2-f.
7
Features of mammorgraphically negative breast tumours.乳腺钼靶检查阴性的乳腺肿瘤特征。
Br J Surg. 1981 Dec;68(12):882-4. doi: 10.1002/bjs.1800681215.
8
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.通过病例对照研究对一项非随机研究(DOM项目)中的乳腺癌筛查进行评估。
Lancet. 1984 Jun 2;1(8388):1224-6. doi: 10.1016/s0140-6736(84)91704-5.
9
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.通过现代乳腺钼靶摄影进行大规模筛查降低乳腺癌死亡率。奈梅亨项目的初步结果,1975 - 1981年
Lancet. 1984 Jun 2;1(8388):1222-4. doi: 10.1016/s0140-6736(84)91703-3.
10
Evaluation of survival data and two new rank order statistics arising in its consideration.生存数据的评估以及在考虑过程中出现的两个新的排序统计量。
Cancer Chemother Rep. 1966 Mar;50(3):163-70.

奈梅亨筛查项目中间隔期癌症的发生情况。

The occurrence of interval cancers in the Nijmegen screening programme.

作者信息

Peeters P H, Verbeek A L, Hendriks J H, Holland R, Mravunac M, Vooijs G P

机构信息

Department of Social Medicine, Nijmegen University, The Netherlands.

出版信息

Br J Cancer. 1989 Jun;59(6):929-32. doi: 10.1038/bjc.1989.196.

DOI:10.1038/bjc.1989.196
PMID:2736229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2246722/
Abstract

Since January 1975 a population-based screening programme for the early detection of breast cancer has been carried out in the city of Nijmegen. During five interscreening periods of 2 years each a total of 158 so-called interval cancers were diagnosed. Careful revision of all screening and diagnostic mammograms was executed. Of all interval cancers 26% were 'missed' at the previous screening examination (due to technical or observer error), 16% were radiographically occult at the time of diagnosis and 58% were 'true' interval cancers. Interval cancers were regarded as 'true' when an obvious lesion was observed on the diagnostic mammogram while no suspect signs were seen on the previous screening mammogram. The prevalence of 'missed' cancers did not decline in the course of the screening programme. Radiographically occult tumours were localised, mostly in Wolfe's P2/DY breast parenchyma (83%), 33% were lobular invasive and 25% ductal non-invasive. 'True' interval cancer cases (58%) showed the same overall survival as control breast cancer patients, diagnosed in a non-screening situation. Shortening the screening interval would reduce interval cancer rates and probably further decrease breast cancer mortality in a screened population. However, from the present series of interval cancers 63% would not have been prevented by an annual screening examination. As regards women under age 50 annual screening would still leave 66% of all interval cancers in this age group undetected. Probably more benefit will be gained by searching for new imaging techniques to reduce numbers of 'missed' cancers and to detect lobular invasive and ductal non-invasive cancers in dense breast parenchyma.

摘要

自1975年1月起,奈梅亨市开展了一项基于人群的乳腺癌早期检测筛查项目。在每两年的五个筛查间期内,共诊断出158例所谓的间期癌。对所有筛查和诊断性乳房X光片进行了仔细复查。在所有间期癌中,26%在之前的筛查检查中“漏诊”(由于技术或观察者失误),16%在诊断时乳房X光片上未显示异常,58%为“真正的”间期癌。当诊断性乳房X光片上观察到明显病变而之前的筛查乳房X光片上未发现可疑迹象时,间期癌被视为“真正的”。在筛查项目过程中,“漏诊”癌的患病率并未下降。乳房X光片上未显示异常的肿瘤大多位于沃尔夫P2/DY型乳腺实质(83%),33%为小叶浸润性癌,25%为导管非浸润性癌。“真正的”间期癌病例(58%)与在非筛查情况下诊断出的对照乳腺癌患者的总生存率相同。缩短筛查间期将降低间期癌发病率,并可能进一步降低筛查人群中的乳腺癌死亡率。然而,从目前的间期癌系列来看,每年进行一次筛查检查无法预防63%的间期癌。对于50岁以下的女性,每年进行筛查仍会漏诊该年龄组所有间期癌的66%。通过寻找新的成像技术以减少“漏诊”癌数量,并在致密乳腺实质中检测小叶浸润性癌和导管非浸润性癌,可能会获得更多益处。